Evidence for superantigenic activity during murine malaria infection

Area of Science:

• Immunology
• Parasitology
• Molecular Biology

Background:

• Plasmodium yoelii is a malaria parasite that infects mice.
• T cell receptor (TCR) usage is crucial for adaptive immunity.
• Polyclonal T cell activation is a known response to certain infections.

Purpose of the Study:

• To investigate TCR V beta usage during Plasmodium yoelii infection.
• To identify any superantigenic-like activities induced by the parasite.
• To understand the impact of parasite-induced T cell modulation on infection susceptibility.

Main Methods:

• Examined TCR V beta usage in C57BL/6 mice infected with Plasmodium yoelii.
• Observed T cell populations (CD4+, CD8+, V beta 9+) in blood and lymph nodes.
• Administered parasite stages (sporozoites, erythrocytic stages) to newborn mice to assess T cell responses.

Main Results:

• A superantigenic-like activity was observed during acute infection, leading to preferential deletion of T cells bearing the TCR V beta 9 segment without prior expansion.
• This deletion of V beta 9+ T cells occurred in blood and lymph nodes regardless of the parasite stage used for infection (sporozoites or erythrocytic stages).
• Neonatal injection of parasite material resulted in peripheral V beta 9+ T cell deletion and anergy, sparing thymic populations, suggesting low-concentration superantigen release during development.

Conclusions:

• Plasmodium yoelii releases a superantigen that selectively deletes specific T cell populations (V beta 9+).
• This parasite-driven immune modulation may play a role in regulating infection.
• Mice lacking V beta 9 T cells (BALB.D2 Mis1a) exhibit heightened susceptibility to P. yoelii, underscoring the protective role of these T cells.